← All trials

NCT06807918

Phase 2/Phase 3Interventional

Trials that are a combination of phases 2 and 3.

View on ClinicalTrials.gov ↗

Timeline

Start date
Feb 28, 2026
Primary completion
Dec 31, 2029
Completion date
Dec 31, 2030
First posted
Feb 4, 2025
Last posted
Nov 19, 2025
Enrollment
60
Arms / groups
3 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.